Christopher J. Endres

3.6k total citations
70 papers, 2.7k citations indexed

About

Christopher J. Endres is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Christopher J. Endres has authored 70 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Radiology, Nuclear Medicine and Imaging, 19 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in Christopher J. Endres's work include Medical Imaging Techniques and Applications (18 papers), HER2/EGFR in Cancer Research (9 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). Christopher J. Endres is often cited by papers focused on Medical Imaging Techniques and Applications (18 papers), HER2/EGFR in Cancer Research (9 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). Christopher J. Endres collaborates with scholars based in United States, Australia and Japan. Christopher J. Endres's co-authors include Jashvant D. Unadkat, Martin G. Pomper, Richard E. Carson, Dean F. Wong, Robert F. Dannals, Dima A. Hammoud, Alan Breier, James Robert Brašić, Peng Hsiao and Badreddine Bencherif and has published in prestigious journals such as Gastroenterology, PLoS ONE and NeuroImage.

In The Last Decade

Christopher J. Endres

70 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher J. Endres United States	29	763	634	596	482	259	70	2.7k
Paolo Zanotti‐Fregonara United States	30	1.1k 1.4×	488 0.8×	534 0.9×	370 0.8×	124 0.5×	113	2.8k
Yoko Ikoma Japan	22	693 0.9×	549 0.9×	335 0.6×	199 0.4×	229 0.9×	95	1.9k
John Hilton United States	31	942 1.2×	704 1.1×	1.2k 2.1×	444 0.9×	234 0.9×	64	3.6k
Jun Toyohara Japan	25	796 1.0×	322 0.5×	747 1.3×	296 0.6×	112 0.4×	144	2.2k
Sandeep Mittal United States	39	1.3k 1.7×	632 1.0×	1.1k 1.8×	449 0.9×	534 2.1×	147	5.6k
Christian Loc’h France	35	1.2k 1.5×	1.1k 1.7×	943 1.6×	231 0.5×	335 1.3×	130	3.4k
Kazumasa Yokoyama Japan	33	634 0.8×	298 0.5×	721 1.2×	259 0.5×	143 0.6×	165	2.9k
Yukio Kimura Japan	28	343 0.4×	401 0.6×	601 1.0×	130 0.3×	242 0.9×	191	2.9k
Toshimitsu Fukumura Japan	28	1.2k 1.5×	485 0.8×	620 1.0×	425 0.9×	90 0.3×	137	2.9k
Guido Slegers Belgium	27	1.1k 1.4×	480 0.8×	921 1.5×	479 1.0×	130 0.5×	166	3.2k

Countries citing papers authored by Christopher J. Endres

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Endres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Endres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Endres more than expected).

Fields of papers citing papers by Christopher J. Endres

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Endres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Endres. The network helps show where Christopher J. Endres may publish in the future.

Co-authorship network of co-authors of Christopher J. Endres

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Endres. A scholar is included among the top collaborators of Christopher J. Endres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Endres. Christopher J. Endres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Templeton, Ian E., Karen Rowland Yeo, Hannah M. Jones, et al.. (2023). Creation of Novel Sensitive Probe Substrate and Moderate Inhibitor Models for a Comprehensive Prediction of CYP2C8 Interactions for Tucatinib. Clinical Pharmacology & Therapeutics. 115(2). 299–308. 3 indexed citations

Mayor, JoAl, et al.. (2023). Effect of Tucatinib on Cardiac Repolarization in Healthy Volunteers. Drugs in R&D. 23(4). 411–419. 1 indexed citations

Sun, Hao, Larry C. Wienkers, Alice Chin, et al.. (2022). Elimination of tucatinib, a small molecule kinase inhibitor of HER2, is primarily governed by CYP2C8 enantioselective oxidation of gem-dimethyl. Cancer Chemotherapy and Pharmacology. 89(6). 737–750. 11 indexed citations

Rubin, Leah H., Ned Sacktor, Jason Creighton, et al.. (2018). Microglial activation is inversely associated with cognition in individuals living with HIV on effective antiretroviral therapy. AIDS. 32(12). 1661–1667. 58 indexed citations

Salinger, David H., Christopher J. Endres, Roland Martinꝉ, & Megan Gibbs. (2014). A semi‐mechanistic model to characterize the pharmacokinetics and pharmacodynamics of brodalumab in healthy volunteers and subjects with psoriasis in a first‐in‐human single ascending dose study. Clinical Pharmacology in Drug Development. 3(4). 276–283. 21 indexed citations

Ravert, Hayden T., Catherine A. Foss, Ronnie C. Mease, et al.. (2013). Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: An agonist probe for the α7 nicotinic acetylcholine receptor. Nuclear Medicine and Biology. 40(6). 731–739. 18 indexed citations

Cho, Steve Y., Kenneth L. Gage, Ronnie C. Mease, et al.. (2012). Biodistribution, Tumor Detection, and Radiation Dosimetry of ¹⁸F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer. Journal of Nuclear Medicine. 53(12). 1883–1891. 217 indexed citations

Dong, Jennifer, David H. Salinger, Christopher J. Endres, et al.. (2011). Quantitative Prediction of Human Pharmacokinetics for Monoclonal Antibodies. Clinical Pharmacokinetics. 50(2). 131–142. 119 indexed citations

Ratchford, John N., Christopher J. Endres, Dima A. Hammoud, et al.. (2011). Decreased microglial activation in MS patients treated with glatiramer acetate. Journal of Neurology. 259(6). 1199–1205. 70 indexed citations

10.

Endres, Christopher J., Martin G. Pomper, Michelle L. James, et al.. (2009). Initial Evaluation of ¹¹C-DPA-713, a Novel TSPO PET Ligand, in Humans. Journal of Nuclear Medicine. 50(8). 1276–1282. 114 indexed citations

11.

Hammoud, Dima A., Christopher J. Endres, Edward R. Hammond, et al.. (2009). Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV. NeuroImage. 49(3). 2588–2595. 31 indexed citations

12.

Brašić, James Robert, Yun Zhou, John L. Musachio, et al.. (2009). Single photon emission computed tomography experience with (S)‐5‐[¹²³I]iodo‐3‐(2‐azetidinylmethoxy)pyridine in the living human brain of smokers and nonsmokers. Synapse. 63(4). 339–358. 17 indexed citations

13.

Endres, Christopher J., et al.. (2009). The Role of Nucleoside Transporters in the Erythrocyte Disposition and Oral Absorption of Ribavirin in the Wild-Type and Equilibrative Nucleoside Transporter 1(−/−) Mice. Journal of Pharmacology and Experimental Therapeutics. 331(1). 287–296. 24 indexed citations

14.

Endres, Christopher J., Cheng Chang, Nagavedi S. Umapathy, et al.. (2006). Electrophysiological Characterization and Modeling of the Structure Activity Relationship of the Human Concentrative Nucleoside Transporter 3 (hCNT3). Molecular Pharmacology. 69(5). 1542–1553. 36 indexed citations

15.

Gorelick, David A., Yu Kyeong Kim, Badreddine Bencherif, et al.. (2005). Imaging Brain Mu-Opioid Receptors in Abstinent Cocaine Users: Time Course and Relation to Cocaine Craving. Biological Psychiatry. 57(12). 1573–1582. 120 indexed citations

16.

Endres, Christopher J. & Jashvant D. Unadkat. (2004). Residues Met89 and Ser160 in the Human Equilibrative Nucleoside Transporter 1 Affect Its Affinity for Adenosine, Guanosine, S6-(4-Nitrobenzyl)-mercaptopurine Riboside, and Dipyridamole. Molecular Pharmacology. 67(3). 837–844. 28 indexed citations

17.

Bencherif, Badreddine, Christopher J. Endres, John L. Musachio, et al.. (2002). PET imaging of brain acetylcholinesterase using [¹¹C]CP‐126,998, a brain selective enzyme inhibitor. Synapse. 45(1). 1–9. 29 indexed citations

18.

Endres, Christopher J., S. Swaminathan, Onofre T. DeJesus, et al.. (1997). Affinities of dopamine analogs for monoamine granular and plasma membrane transporters: Implications for PET dopamine studies. Life Sciences. 60(26). 2399–2406. 23 indexed citations

19.

Kiesewetter, Dale O., Richard E. Carson, Elaine M. Jagoda, et al.. (1997). In vivo muscarinic binding selectivity of (R,S)- (R,R)- QNB. Bioorganic & Medicinal Chemistry. 5(8). 1555–1567. 14 indexed citations

20.

DeJesus, Onofre T., Dhanabalan Murali, Christopher J. Endres, et al.. (1994). Evaluation of 3-[18F]Fluoro-α-fluoromethyl-p-tyrosine as a tracer for striatal tyrosine hydroxylase activity. Nuclear Medicine and Biology. 21(4). 663–667. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact